How to make hypericin water-soluble

Pharmazie

Volumn 63, Issue 4, 2008, Pages 263-269

  Kubin, Andreas ^a   Loew, H G ^a   Burner, U ^a   Jessner, G ^a   Kolbabek, H ^a   Wierrani, F ^a  

^a Department of Experimental Physics ^*  (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

3 TETRAHYDROXYPHENYLCHLORIN POLYVINYLPYRROLIDONE 25 COMPLEX; HYPERICIN; HYPERICIN POLYVINYLPYRROLIDONE 10 COMPLEX; HYPERICIN POLYVINYLPYRROLIDONE 25 COMPLEX; HYPERICIN POLYVINYLPYRROLIDONE 40 COMPLEX; PHOTOSENSITIZING AGENT; UNCLASSIFIED DRUG;

AQUEOUS SOLUTION; ARTICLE; CHEMICAL BOND; CONTROLLED STUDY; DIAGNOSTIC VALUE; DRUG CONJUGATION; DRUG FORMULATION; DRUG MIXTURE; FLUORESCENCE ANALYSIS; HUMAN; HUMAN CELL; PHOTODYNAMIC THERAPY; PHYSICAL CHEMISTRY; POLYMERIZATION; WATER ABSORPTION;

ANTIDEPRESSIVE AGENTS; CARCINOMA, TRANSITIONAL CELL; CHEMISTRY, PHYSICAL; DRUG DELIVERY SYSTEMS; FLOW CYTOMETRY; HUMANS; HYDROGEN BONDING; K562 CELLS; LEUKOCYTES; PERYLENE; PHARMACEUTIC AIDS; PHOTOCHEMISTRY; POVIDONE; SOLUBILITY; SPECTROMETRY, FLUORESCENCE; WATER;

EID: 42149164900     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: 10.1691/ph.2008.7292     Document Type: Article

References (47)

1. Alecu M, Ursaciuc C, Halalau F, Coman G, Merlevede W, Waelkens E, de Witte, P (1998) Photodynamic treatment of basal cell carcinoma and squamous cell carcinoma with hypericin. Anticancer Res 18: 4651-4654.
2. Ali SM, Olivo M (2002) Bio-distribution and subcellular localization of Hypericin and its role in PDT induced apoptosis in cancer cells. Int J Oncol 21: 531-540.
3. Ali SM, Olivo M (2003) Mechanisms of action of phenanthroperylenequinones in photodynamic therapy (review). Int J Oncol 22: 1181-1191.
4. Althof S (2005) Das Harnsediment. Thieme Verlag, Stuttgart New York, ISBN 3135324060.
5. Bezdetnaya L, Zeghari N, Belitchenko I, Barberi-Heyob M, Merlin JL, Potapenko A, Guillemin F (1996) Spectroscopic and biological testing of photobleaching of porphyrins in solutions. Photochem Photobiol 64: 382-386.
6. Bonnett R, Djelal BD, Hamilton PA, Martinez G, Wierrani, F (1999) Photobleaching of 5, 10, 15, 20-tetrakis (m-hydroxyphenyl) porphyrin (m-THPP) and the corresponding chlorin (m-THPC) and bacteriochlorin (m-THPBC). A comparative study. J Photochem Photobiol B Biol 53: 136-143.
7. Brockmoller J, Reum T, Bauer S, Kerb R, Hubner WD, Roots I (1997) Hypericin and pseudohypericin: pharmacokinetics and effects on photosensitivity in humans. Pharmacopsychiatry 30: 94-101.
8. Chen B, Xu Y, Roskams T, Delaey E, Agostinis P, Vandenheede JR, de Witte P (2001) Efficacy of antitumoral photodynamic therapy with hypericin: relationship between biodistribution and photodynamic effects in the RIF-1 mouse tumor model. Int J Cancer 93: 275-282.
9. Chen B, Roskams T, de Witte PA (2002a) Antivascular tumor eradication by hypericin-mediated photodynamic therapy. Photochem Photobiol 76: 509-513.
10. Chen B, Roskams T, de Witte PA (2002b) Enhancing the antitumoral effect of hypericin-mediated photodynamic therapy by hyperthermia. Lasers Surg Med 31: 158-163.
11. Coulin F, Power CA, Alouani S, Peitsch MC, Schroeder JM, Moshizuki M, Clark-Lewis I, Wells TN (1997) Characterisation of macrophage inflammatory protein-5/human CC cytokine-2, a member of the macrophage-inflammatory-protein family of chemokines. Eur J Biochem 248: 507-515.
12. D'Hallewin MA, De Witte PA, Waelkens E, Merlevede W, Baert L (2000) Fluorescence detection of flat bladder carcinoma in situ after intravesical instillation of hypericin. J Urol 164: 349-351.
13. D'Hallewin MA, Bezdetnaya L, Guillemin F (2002a) Fluorescence detection of bladder cancer: a review. Eur Urol 42: 417-425.
14. D'Hallewin MA, Kamuhabwa AR, Roskams T, De Witte PA, Baert L (2002b) Hypericin-based fluorescence diagnosis of bladder carcinoma. BJU Int 89: 760-763.
15. Diwu Z (1995) Novel therapeutic and diagnostic applications of hypocrellins and hypericins. Photochem Photobiol 61: 529-539.
16. Dougherty TJ, Marcus SL (1992) Photodynamic therapy. Eur J Cancer 28A: 1734-1742.
17. Falk H, Meyer J (1994) On the homo- and heteroassociation of hypericin. Monatsh Chem 125: 753-762.
18. Falk H, Mayr E (1995) Synthesis and properties of fringelite D (1, 3, 4, 6, 8, 10, 11, 13-octahydroxy-phenanthrol, 10, 9, 8, o, p, q, r, aperylene-7, 14-dione). Monatsh Chem 126: 699-710.
19. Falk H (1999) From the photosensitizer hypericin to the photoreceptor stentorin- the chemistry of phenanthroperylene quinones. Angew Chem Int Ed Engl 38: 3116-3136.
20. Freitas I, Baronzio GF (1991) Tumor hypoxia, reoxygenation and oxygenation strategies: possible role in photodynamic therapy. J Photochem Photobiol B 11: 3-30.
21. Hadjur C, Richard MJ, Parat MO, Favier A, Jardon P (1995) Photodynamically induced cytotoxicity of hypericin dye on human fibroblast cell line MRC5. J Photochem Photobiol B 27: 139-146.
22. Henderson BW, Dougherty TJ (1992) How does photodynamic therapy work? Photochem Photobiol 55: 145-157.
23. Kerb R, Brockmoller J, Staffeldt B, Ploch M, Roots I (1996) Single-dose and steady-state pharmacokinetics of hypericin and pseudohypericin. Antimicrob Agents Chemother 40: 2087-2093.
24. Kil KS, Yum YN, Seo SH, Lee KT (1996) Antitumor activities of hypericin as a protein tyrosine kinase blocker. Arch Pharm Res 19: 490-496.
25. rd May, 2000.
26. Kubin A, Kolbabek H, Jindra RH, Dobrovsky W, Alth G, Wierrani F (2000b) Photodynamic therapy by local application of hypericin - A case report. Res Adv Photochem Photobiol 1: 147-153.
27. Kubin A, Burner U, Loew HG, Wierrani F, Kolbabek H, Alth G (2003a) Hypericin complex bound to polyvinylpyrrolidone (PVP) - a novel therapeutic and diagnostic application?, American Society for Photobiology, 31st Annual Meeting, Baltimore, abstract 226.
28. Kubin A, Loew HG, Burner U, Wierrani F, Kolbabek H, Alth G (2003b) Water soluble hypericin complex bound to polyvinylpyrrolidone (PVP), 10th Congress of the European Society for Photobiology, Vienna, abstract P060.
29. Kubin A, Wierrani F, Burner U, Alth G, Grunberger W (2005) Hypericin - the facts about a controversial agent. Curr Pharm Des 11: 233-253.
30. Liebes L, Mazur Y, Freeman D, Lavie D, Lavie G, Kudler N, Mendoza S, Levin B, Hochster H, Meruelo D (1991) A method for the quantitation of hypericin, an antiviral agent, in biological fluids by high-performance liquid chromatography. Anal Biochem 195: 77-85.
31. Malkin J, Mazur Y (1993) Hypericin derived triplet states and transients in alcohols and water. Photochem Photobiol 57: 929-933.
32. Manyak MJ, Russo A, Smith PD, Glatstein E (1988) Photodynamic therapy. J Clin Oncol 6: 380-391.
33. Moan J, Streckyte G, Bagdonas S, Bech O, Berg K (1997) Photobleaching of protoporphyrin IX in cells incubated with 5-aminolevulinic acid. Int J Cancer 70: 90-97.
34. Ochsner M (1997a) Photodynamic therapy: the clinical perspective. Review on applications for control of diverse tumorous and non-tumorous diseases. Arzneimittelforsch 47: 1185-1194.
35. Ochsner M (1997b) Photophysical and photobiological processes in the photodynamic therapy of tumours. J Photochem Photobiol B 39: 1-18.
36. Olivo M, Lau W, Manivasager V, Tan PH, Soo KC, Cheng C (2003) Macromicroscopic fluorescence of human bladder cancer using hypericin fluorescence cystoscopy and laser confocal microscopy. Int J Oncol 23: 983-990.
37. Pytel A, Schmeller N (2002) New aspect of photodynamic diagnosis of bladder tumors: fluorescence cytology. Urology 59: 216-219.
38. Römpp (1995) In Chemie Lexikon Version 1.0. Thieme Verlag, Stuttgart.
39. Senthil V, Longworth JW, Ghiron CA, Grossweiner LI (1992) Photosensitization of aqueous model systems by hypericin. Biochim Biophys Acta 1115: 192-200.
40. Thomas C, Pardini RS (1992) Oxygen dependence of hypericin-induced phototoxicity to EMT6 mouse mammary carcinoma cells. Photochem Photobiol 55: 831-837.
41. Uzdensky AB, Bragin DE, Kolosov MS, Kubin A, Loew HG, Moan J (2003) Photodynamic effect of hypericin and a water-soluble derivative on isolated crayfish neuron and surrounding glial cells. J Photochem Photobiol B 72: 27-33.
42. Van Hillegersberg R, Kort WJ, Wilson JH (1994) Current status of photodynamic therapy in oncology. Drugs 48: 510-527.
43. Vandenbogaerde AL, Kamuhabwa A, Delaey E, Himpens BE, Merlevede WJ, de Witte PA (1998) Photocytotoxic effect of pseudohypericin versus hypericin. J Photochem Photobiol B 45: 87-94.
44. VanderWerf QM, Saxton RE, Chang A, Horton D, Paiva MB, Anderson J, Foote C, Soudant J, Mathey A, Castro DJ (1996) Hypericin: a new laser phototargeting agent for human cancer cells. Laryngoscope 106: 479-483.
45. Wirz A, Meier B, Sticher O (2001) Absorbance data of hypericin and pseudohypericin used as reference compounds for medicinal plant analysis. Pharmazie 56: 52-57.
46. Wirz A, Meier B, Sticher O (2002) Solubility of hypericin in methanol and methanolpyridine. Pharmazie 57: 543-545.
47. Wynn JL, Cotton TM (1995) Spectroscopic properties of hypericin in solution and at surfaces. J Phys Chem 99: 4317-4323.